1-4 of 4
Nicolas Vantard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A New Simplified Prognostic Index Integrating the Type of Extra-Nodal Involvement and Age for Ann Arbor Stage IV Hodgkin Lymphoma Patients Diagnosed at TEP-Scanner Era: A Retrospective Analysis from Lymphoma Study Association (LYSA) Centers

Camille Golfier, Delphine Maucort-Boulch, MD PhD, Emmanuelle Nicolas-Virelizier, MD, Cedric Rossi, MD, Pierre Sesques, MD, Nicolas Vantard, PharmD, Bertrand Favier, PharmD, PhD, Emmanuel Bachy, MD PhD, Florence Broussais-Guillaumot, MD, Emmanuelle Ferrant, MD, Dana Ghergus, MD, Lionel Karlin, MD, Anne Lazareth, MD, Violaine Safar, MD, Clementine Sarkozy, MD, Souad Assaad, MD, Laure Lebras, MD, Philippe Rey, MD, Jean-Noel Bastie, MD PhD, Alexandra Traverse-Glehen, MD PhD, Laurent Martin, MD PhD, Jeremie Tordo, MD, Alina Berriolo-Riedinger, MD, Gilles Salles, MD PhD, Rene-Olivier Casasnovas, MD, Herve Ghesquieres, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1629.
https://doi.org/10.1182/blood-2018-99-118578
Published: 2018
Journal Articles

Ritumixab in Combination with Adapted-Dose of Ifosfamide and Etoposide As Salvage Treatment in Elderly Refractory/Relapsed Diffuse Large B-Cell Lymphoma Patients Non-Candidate for High Dose Therapy: A Retrospective Study of Lyon Hospital University

Guillaume Aussedat, Delphine Maucort-Boulch, MD PhD, Philippe Rey, MD, Violaine Safar, MD, Lionel Karlin, MD, Mad-Helenie Elsensohn, Msc, Laure Lebras, MD, Clementine Sarkozy, MD, Emmanuel Bachy, MD PhD, Bertrand Favier, PharmD, PhD, Nicolas Vantard, PharmD, Pierre Sesques, MD, Anne Lazareth, MD, Emmanuelle Ferrant, MD, Dana Ghergus, MD, Gilles Salles, MD PhD, Emmanuelle Nicolas-Virelizier, MD, Herve Ghesquieres, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4215.
https://doi.org/10.1182/blood-2018-99-116734
Published: 2018
Journal Articles

Prospective Analysis of the Quality of Life of Chronic Phase CML Patients on Second Generation Tyrosine Kinase Inhibitors after Imatinib Failure. an Observational Study

Franck E. Nicolini, MD PhD, Nicolas Vantard, Pharm.D, Stephane Giraudier, MD PhD, Mael Heiblig, MD, Hyacinthe Johnson-Ansah, MD, Lydia Roy, MD, Claude-Eric Bulabois, MD, Denis Caillot, MD, Martine Escoffre-Barbe, MD, Eric Jourdan, MD PhD, Pascale Cony-Makhoul, MD, Agnes Guerci-Bresler, MD PhD, Laurence Legros, MD PhD, Laurent Sutton, MD, Martine Gardembas, MD, Emmanuel Gyan, MD PhD, Annelore Le Maux, Stat., Carine Guinard-Azadian, MD, Hesham Mohamed, MD, Mohamad Sobh, Pharm.M., Helene Labussiere-Wallet, MD, Gabriel Etienne, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1321.
https://doi.org/10.1182/blood.V124.21.1321.1321
Published: 2014
Journal Articles

Tacrolimus Extended Release Formulation Given As An Alternative To Ciclosporine A In Case Of Renal Impairment After Allogeneic HSCT: Results From a Prospective Pilot Study

Marie Y. Detrait, MD, Stephane Morisset, Sabine Cohen, Monique Manchon, Verane Schwiertz, Florence Ranchon, Nicolas Vantard, Caroline Serrier, MD, Adrien Quintela, Christiane Cazac, Carole Hospital, Valerie Chapel, Sothiny Sar, Catherine Rioufol, Mauricette Michallet, MD, PhD, Fiorenza Barraco, MD
Journal: Blood
Blood (2013) 122 (21): 4549.
https://doi.org/10.1182/blood.V122.21.4549.4549
Published: 2013